Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis

Rheumatology International

Volumn 34, Issue 10, 2014, Pages 1455-1458

  Ungprasert, Patompong ^a   Sanguankeo, Anawin ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Deep venous thrombosis; Dermatomyositis; Idiopathic inflammatory myositis; Meta analysis; Polymyositis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

COMPLICATION; HUMAN; META ANALYSIS; MYOSITIS; RISK; VENOUS THROMBOEMBOLISM;

HUMANS; MYOSITIS; RISK; VENOUS THROMBOEMBOLISM;

EID: 84918816715     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3023-1     Document Type: Article

References (17)

1. Naess IA, Christiansen SC, Romundstad P et al (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699
2. Heit JA, Silverstein MD, Mohr DN et al (1999) Predictor of survival after deep venous thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159:445–453
3. Nagareddy P, Smyth SS (2013) Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol 20:457–463
4. Silvarino R, Danza A, Merola V, Berez A, Mendez E, Espinosa G, Cervera R (2012) Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind. Autoimmun Rev 12:289–294
5. Ungprasert P, Srivali N, Spanuchart I et al (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 33:297–304
6. Miehsler W, Reinisch W, Valic E et al (2005) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–548
7. Selva-O’callaghan A, Fernandez-Luque A, Martinez-Gomez X et al (2011) Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol 29:846–849
8. Gaitonde SD, Ballou SP (2008) Deep venous thrombosis in dermatomyositis. J Rheumatol 35(11):2288
9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188
10. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
11. Ramagopalan SV, Wotton CJ, Handel AE et al (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1
12. Zoller B, Li X, Sunquist J, Sunquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379:244–249
13. Johannesdottir SA, Schmidt M, Horvath-Puho E et al (2012) Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case–control study. J Thromb Haemost 10:815–821
14. Biasillio G, Leo M, Della Bona R et al (2010) Inflammatory biomarker and coronary artery disease: from bench to bedside and back. Intern Emerg Med 5:225–233
15. Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231
16. Fumery M, Xiaocang C, Dauchet L et al (2013) Thrombotic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis, 29 Oct 2013 [Epub ahead of print]
17. Ungprasert P, Leeaphorn N, Hosiriluck N et al (2013) Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013:509354